PGP and breast carcinoma: Because breast cancers also express high levels of P-gp, and since we have validated that SipA enhances the cytotoxic activity of breast adenocarcinoma cells (above), we next assessed the broad-spectrum capabilities of the SipA nanoparticle mimic in a humanized mouse model36, 37 of primary human breast cancer.